Treatment of head and neck cancers: issues for clinical pharmacists.
Scarpace, Sarah L
Treatment of head and neck cancers: issues for clinical pharmacists. [electronic resource] - Pharmacotherapy May 2009 - 578-92 p. digital
Publication Type: Journal Article; Review
1875-9114
10.1592/phco.29.5.578 doi
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Antineoplastic Agents--adverse effects
Carboplatin--therapeutic use
Cetuximab
Cisplatin--therapeutic use
Combined Modality Therapy
Dermatitis--etiology
Head and Neck Neoplasms--complications
Humans
Medication Therapy Management
Mucositis--etiology
Pharmaceutical Services
Radiotherapy--adverse effects
Survival Analysis
Xerostomia--etiology
Treatment of head and neck cancers: issues for clinical pharmacists. [electronic resource] - Pharmacotherapy May 2009 - 578-92 p. digital
Publication Type: Journal Article; Review
1875-9114
10.1592/phco.29.5.578 doi
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Antineoplastic Agents--adverse effects
Carboplatin--therapeutic use
Cetuximab
Cisplatin--therapeutic use
Combined Modality Therapy
Dermatitis--etiology
Head and Neck Neoplasms--complications
Humans
Medication Therapy Management
Mucositis--etiology
Pharmaceutical Services
Radiotherapy--adverse effects
Survival Analysis
Xerostomia--etiology